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Abstract
 
The homeobox genes encode a family of transcription factors that regulate development and
postnatal tissue homeostasis. Since HOXB4 plays a key role in regulating the balance between
hematopoietic stem cell renewal and differentiation, we studied the molecular regulation of
HOXB4 expression in human hematopoietic stem cells. HOXB4 expression in K562 cells is
regulated at the level of transcription, and transient transfection defines primary HOXB4 regu-
latory sequences within a 99-bp 5
 
9
 
 promoter. Culture of highly purified human CD34
 
1
 
 bone
marrow cells in thrombopoietin/Flt-3 ligand/stem cell factor induced HOXB4 3–10-fold,
whereas culture in granulocyte/macrophage colony-stimulating factor, only increased HOXB4/
 
luciferase
 
 
 
expression 20–50%. Mutations within the HOXB4 promoter identified a potential E
box binding site (HOX response element [HXRE]-2) as the most critical regulatory sequence,
and yeast one hybrid assays evaluating bone marrow and K562 libraries for HXRE-2 interac-
tion identified upstream stimulating factor (USF)-2 and micropthalmia transcription factor
(MITF). Electrophoretic mobility shift assay with K562 extracts confirmed that these proteins,
along with USF-1, bind to the HOXB4 promoter in vitro. Cotransfection assays in both K562
and CD34
 
1
 
 cells showed that USF-1 and USF-2, but not MITF, induce the HOXB4 pro-
moter in response to signals stimulating stem cell self-renewal, through activation of the mito-
gen-activated protein kinase pathway. Thus hematopoietic expression of the human HOXB4
gene is regulated by the binding of USF-1 and USF-2, and this process may be favored by cy-
tokines promoting stem cell self-renewal versus differentiation.
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Introduction
 
The homeobox genes comprise a family of genes that play
a pivotal role in embryonic pattern formation and organo-
genesis. Over the past several decades, studies in species
ranging from 
 
Drosophila
 
 to humans have identified genes in
these families as critical to such processes as limb formation,
vertebral orientation and sequencing, and formations of
whole organs such as the pancreas and spleen. In addition
to their critical role in embryonic development, homeobox
genes also appear to direct tissue-specific homeostasis be-
tween cellular compartments. In this role homeobox tran-
scription factors, rather than dictating pattern formation
which evolves over time, serve to maintain the balance of
cellular compartmentalization and/or geometric orienta-
tion critical to maintaining tissue homeostasis during cell
turnover (1–4).
In hematopoietic stem cell physiology, HOX genes
maintain the critical ratio of stem cells to specifically differ-
entiated blood cells throughout life. Studies in several labo-
ratories demonstrated that the expression of several ho-
meobox genes varies with stem cell differentiation (5–8).
Of particular interest are the HOXA10, HOXB3, and
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HOXB4 genes, which are abundantly expressed in primi-
tive hematopoietic cells, but then decline with lineage-spe-
cific terminal differentiation. Subsequent experiments have
confirmed that expression of these genes is directly linked
to maintenance of primitive stem cell phenotypes (9, 10).
Enforced expression of HOXA10 and B3 in retrovirally
transduced mouse hematopoietic cells resulted in a cellular
phenotype resembling acute leukemia (11, 12). On the
other hand, enforced expression of HOXB4 produced stem
cells that have amplified competitive repopulating ability in
cotransplant models, although producing more intermedi-
ate level progenitor cells per stem cell transplanted (13).
These studies suggest that the molecular regulation of ho-
meobox gene expression is a critical nodal point in stem
cell self-renewal decisions.
Therefore, we have analyzed the molecular basis of
HOXB4 expression in human hematopoietic cells, using
both the K562 cell line and normal CD34
 
1
 
 human bone
marrow cells. Our results demonstrate that HOXB4 ex-
pression is strongly regulated by a 99-bp promoter embed-
ded within a larger 5
 
9
 
 flanking sequence which is highly
conserved among species. In contrast to their regulation in
neural and mesodermal development, intronic and 3
 
9
 
 se-
quences appear to have a less dominant role. HOXB4 tran-
scription is induced by the binding of upstream stimulatory
factor (USF)
 
1
 
-1 and USF-2 to these sequences, while bind-
ing of microphthalmia transcription factor (MITF) binds
but does not induce HOXB4 transcription. These results
suggest a model in which transcription factor competition
for binding to the HOXB4 promoter influences the self-
renewal status of hematopoietic stem cells.
 
Materials and Methods
 
HOXB4 Genomic Cloning.
 
A genomic clone containing the
human HOXB4 gene was isolated from a human genomic pla-
cental library (CLONTECH Laboratories, Inc.) by hybridization
with a 256-bp HOXB4 probe provided by Jeffrey Lawrence,
M.D. (University of California at San Francisco, San Francisco,
CA). The clone was restriction mapped, sequenced, and regions
corresponding to the coding sequence and 5
 
9 
 
and 3
 
9
 
 noncoding
sequences were identified. The complete genomic nucleotide se-
quence was submitted to EMBL/GenBank/DDBJ, and is avail-
able under accession no. AF307160. Digested subclones were
cloned into a luciferase reporter vector, PGL3 (Promega).
 
Mutagenesis. 
 
Mutations were introduced into specific clone
sequences by site-directed mutagenesis using the Altered Sites II
Mutagenesis system (Promega). All mutations were confirmed by
DNA sequence analysis. For the experiments described, the NF1
site in the transcriptionally active HOXB4 promoter was mutated
 
from ATTGGCT to A
 
AC
 
GGCT, and the E box was mutated
from CACGTG to CA
 
TA
 
TG.
 
Cell Preparation and Culture.
 
K562, U937, and KG1a cells
(American Type Culture Collection) were grown in RPMI 1640
supplemented with 10% fetal bovine serum (GIBCO BRL), 10
U/ml penicillin, and 10 
 
m
 
g/ml streptomycin.
CD34
 
1
 
 cells from human bone marrow were harvested from
healthy donors, according to a protocol approved by the Univer-
sity of Pennsylvania Medical School Institutional Review Board.
Mononuclear cells were isolated by centrifugation over Ficoll-
Hypaque, and CD34
 
1
 
 cells were isolated by adherence depletion
followed by immunoselection using an MS
 
1
 
/RS
 
1
 
 Minimacs col-
umn (Miltenyi Biotec). The selected cells were 
 
.
 
95% CD34
 
1
 
upon reanalysis by flow cytometry. For the analysis of HOXB4
constructs after electroporation, these enriched cells were incu-
bated for 48 h in IMDM supplemented with 10% human umbili-
cal cord serum (HUCS) plus 10 U/ml penicillin and 10 
 
m
 
g/ml
streptomycin. Cells were cultured in 100 ng/ml Flt-3 ligand (Flt-
3l), 100 ng/ml stem cell factor (SCF), and 100 ng/ml throm-
bopoietin (TPO) to promote proliferation with stem cell self-
renewal, or in 20 ng/ml GM-CSF to promote proliferation with
terminal myeloid maturation. Cultured cells were stained with
PE–anti-CD34 and PE–anti-CDllb to assay for the persistence of
primitive progenitor cells and the appearance of differentiated
myeloid cells.
 
Northern Analysis.
 
 
 
K562 cell cultures were supplemented
with 10
 
2
 
7
 
 M PMA (Sigma-Aldrich). PolyA
 
1
 
 RNA was isolated
with Trizol (GIBCO BRL) followed by affinity purification us-
ing an Oligotex mRNA kit (QIAGEN). 2.5 
 
m
 
g of PolyA
 
1
 
 RNA
was electrophoresed on a formaldehyde-formamide agarose gel
and transferred onto nylon membrane. The mRNA was analyzed
for levels of HOXB4 expression by hybridization with a 1,262-
bp HOXB4 probe radiolabeled with [
 
a
 
-
 
32
 
P]dCTP (Amersham
Pharmacia Biotech) via random priming. The radiolabeled probe
and the mRNA blot were hybridized in 50% formamide, 0.12 M
Na
 
2
 
HPO
 
4,
 
 pH 7.2, 0.25 M NaCl, and 7% SDS (Bio-Rad Labora-
tories) at 42
 
8
 
C overnight.
 
Nuclear Run-on. 
 
Nuclei were isolated from 25 
 
3 
 
10
 
6
 
 K562
cells that were induced to proliferate and differentiate towards
monocytes by addition of 10
 
2
 
7
 
 M PMA. The nuclei were tran-
scribed with 100 
 
m
 
Ci [
 
a
 
-
 
32
 
P]UTP (Dupont/NEN Life Science
Products) for 1 h at 30
 
8
 
C with shaking. To retrieve the newly
transcribed radiolabeled RNA, the nuclei were treated with 40
 
m
 
g of RNase-free DNase I (Roche) and 200 
 
m
 
g of proteinase K.
The RNA was extracted with phenol/chloroform/isoamyl alco-
hol and then separated on a G-50 Sephadex column. The radiola-
beled RNA was hybridized in 50% formamide, 0.12 M
Na
 
2
 
HPO
 
4
 
, pH 7.2, 0.25 M NaCl and 7% SDS to 10 
 
m
 
g of DNA
encoding the 3
 
9
 
 untranslated HOXB4 cloned into the PCI vec-
tor, or 10 
 
m
 
g of control PCI vector alone, which were cross-
linked to a Zeta Probe membrane (Bio-Rad Laboratories) for
24 h at 42
 
8
 
C.
 
5
 
9
 
 Rapid Amplification of cDNA Ends.
 
A modification of 5
 
9
 
rapid amplification of cDNA ends (RACE) (Takara Biomedicals)
was performed using HOXB4-specific primers for reverse tran-
scription, followed by a circularization by RNA ligase. Amplifi-
cation was performed in two rounds using specifically designed
oligonucleotide primers. Fragments were cloned and sequenced.
 
Plasmids.
 
USF-1 cDNA was obtained as described previously
(14). Dominant negative (D/N) USF and D/N
 
 
 
MITF clones
were constructed as described previously (15). The D/N
 
 
 
USF
contains a deletion of amino acids 132–212 in the USF basic re-
gion, whereas the D/N MITF consists of a TFE3 encoding plas-
 
1
 
Abbreviations used in this paper:
 
 DMSO, dimethyl sulfoxide; D/N, domi-
nant negative; EGFP, enhanced green fluorescent protein; EMSA, elec-
trophoretic mobility shift assay; HOX, homeobox; HLH, helix loop he-
lix; HUCS, human umbilical cord serum; HXRE, HOX response
element; MAPK, mitogen-activated protein kinase; MEK, MAPK kinase;
MITF, microphthalmia transcription factor; PI3K, phosphatidylinositol
3-kinase; RACE, rapid amplification of cDNA ends; SCF, stem cell fac-
tor; TPO, thrombopoietin; USF, upstream stimulatory factor. 
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mid containing a deletion in amino acids 89–107, also in the basic
region. These deletions destroy the DNA binding activities of
these proteins without impairing their ability to dimerize with
their cognate cellular proteins (USF-1 or USF-2 for D/N
 
 
 
USF,
MITF or TFE3 for D/N MITF). The clone encoding constitu-
tively active RAS V12, in pCDNA3, was a gift from Dr. Len
Stephens (Babraham Institute, Cambridge, UK). A D/N
 
 
 
mito-
gen-activated protein kinase (MAPK) kinase (MEK)1 K97A con-
struct was subcloned into pcDNA3zeo, and D/N
 
 
 
phosphatidyl-
inositol 3-kinase
 
 
 
(PI3K) (p85 
 
D
 
478–513) was cloned into
pCMV5, as described previously (16). The soluble MEK inhibi-
tor PD98059 (Parke Davis) was added at 100 
 
m
 
M in DMSO as
described previously (17).
 
Transient Transfection.
 
K562 cells were grown to 0.5–1 
 
3 
 
10
 
6
 
cells/ml, washed, and then transfected with 10–20 
 
m
 
g of DNA by
the DEAE-dextran method as described previously (18) or by
electroporation. Aliquots of 10
 
7
 
 cells were washed once in com-
plete medium (RPMI 1640 plus 10% fetal bovine serum plus
penicillin/streptomycin), resuspended to 10
 
7
 
 cells/300 
 
m
 
l in com-
plete medium and then transferred to a 0.4-cm electroporation
cuvette (Bio-Rad Laboratories). A total of 10–20 
 
m
 
g of DNA was
added and the cuvette was electroporated at 200 V, 950 
 
m
 
F
(Gene Pulser; Bio-Rad Laboratories). After 10 min, the cells
were plated in complete medium at 0.5 
 
3 
 
10
 
6
 
 cells /ml. 2 
 
m
 
g of
either pSVBgal or PCH110, encoding 
 
b
 
-galactosidase, was in-
cluded in each transfection to normalize transfection efficiency.
36–48 h after transfection, K562 cells were lysed using Reporter
Lysis buffer (Promega) and the protein concentrations were mea-
sured (DC Protein Assay; Bio-Rad Laboratories). Luciferase as-
says with equal amounts of protein were performed using Lu-
ciferase substrate (Promega) and a luminometer (Monolight 2010;
Analytical Luminescence Laboratories), with 
 
b
 
-galactosidase as-
says performed on all samples to control for transfection effi-
ciency.
CD34
 
1
 
 cells were stimulated with Flt-3l (100 ng/ml)/SCF
(100 ng/ml)/TPO (100 ng/ml) (R & D Systems) for 72 h before
electroporation. For each sample, 2 
 
3 
 
10
 
6
 
 cells were washed, re-
suspended in 400 
 
m
 
l of electroporation media, and then trans-
ferred to a 0.4-cm electroporation cuvette (Bio-Rad Laborato-
ries). 30 
 
m
 
g of experimental DNA and 1 
 
m
 
g of a renilla luciferase
control vector (Promega) were added and the sample was elec-
troporated at 240 V, 950 
 
m
 
FD (Gene Pulsar; Bio-Rad Laborato-
ries). After 10 min, the electroporated cells were plated at 1–2 
 
3
 
10
 
6
 
 cells/ml and cultured for 48 h in Flt-3l/SCF/TPO, or in
GM-CSF. The cytokine-stimulated CD34
 
1
 
 cells were then lysed
(Promega) and luciferase activity was measured. To control for
electroporation efficiency within each sample, the renilla lu-
ciferase control was measured by quenching the luciferase lumi-
nescence and simultaneously activating the sea pansy renilla activ-
ity. For immunofluorescence studies, promoter constructs were
subcloned into Pgreen Lantern (GIBCO BRL) in place of the
CMV promoter. Promoter activation was detected by immuno-
fluorescence 48 h after electroporation.
 
Stable HOXB4 Promoter K562 Transformants.
 
K562 cells were
grown to 0.5–1.0 
 
3 
 
10
 
6
 
 cells/ml, washed, and then transfected
with 20 
 
m
 
g of either the native 99-bp HOX promoter cloned
into PGL3 (Promega), the HOX response element (HXRE)-1
mutated HOXB4 promoter/PGL3, HXRE-2 mutated HOXB4
promoter/PGL3, or PGL3 alone, along with 1 
 
m
 
g PCMV-script-
neo by electroporation as stated above. 48 h after transfection, the
neomycin-resistant K562 cells were selected with 1 mg/ml G418
(GIBCO BRL) for 7 d. Luciferase assays with equal amounts of
protein were performed as per the manufacturer’s instructions us-
 
ing luciferase substrate and a Monolight 2010 Luminometer. To
control for position effects within individual clones, all experi-
ments were performed with pooled, selected cells.
 
Electrophoretic Mobility Shift Assays.
 
A 99-bp (extending from
 
2
 
153 to 
 
2
 
55 from the ATG) double-stranded fragment with a
5
 
9
 
 overhang was radiolabeled with [
 
a
 
-
 
32
 
P]dCTP and Klenow
fragment (New England Biolabs, Inc.). Nuclear extracts were
prepared from K562 cells. In a typical electrophoretic mobility
shift assay (EMSA), 2.5 
 
m
 
g of nuclear extract was incubated at
room temperature for 10 min in binding buffer (4% glycerol, 1
mM MgCl
 
2
 
, 0.5 mM EDTA, 0.5 mM dithiothreitol, 50 mM
NaCl, 10 mM Tris, pH 7.5, 2.5 
 
m
 
g dIdC). Radiolabeled probe
(50,000 disintegrations/s) was added to the tube, and the reaction
was allowed to continue for 20 min at room temperature. Sam-
ples were loaded onto a 4% polyacrylamide nondenaturing gel
and electrophoresed at room temperature for 4 h in 0.5% Tris-
boric acid-EDTA buffer.
To identify specific DNA binding proteins in K562 nuclear
extracts, supershift assays were performed. A 20-bp fragment
(HOXB4 2149 to 2129) was radiolabeled and incubated with
nuclear extracts as above in the presence or absence of 2.5 mg
anti-MITF antibody (gift from David Fisher and Timothy
Hemesath, Dana-Farber Cancer Institute, Boston, MA), 1 mg
anti–USF-1 (Santa Cruz Biotechnology, Inc.), 1 mg anti–USF-2
(Santa Cruz Biotechnology, Inc.), or 2.5 mg normal mouse IgG.
The antibody–nuclear extract–DNA complexes were then elec-
trophoresed as above and retarded bands were detected after
transfer and autoradiography.
Yeast One Hybrid Screen. Candidate cDNA encoding proteins
that bind to the HXRE-2 site were isolated from K562 and hu-
man bone marrow cDNA libraries by fusion with Gal4 activation
domain and yeast one hybrid selection using the Matchmaker sys-
tem (CLONTECH Laboratories, Inc.). Three tandem copies of
the HXRE-2 site (2129 to 2149 bp) were cloned upstream of
the His3 coding region in the pHISi one hybrid vector, and this
construct was integrated into the yeast (YM4271) genome. This
reporter strain was then transformed with the Gal4 AD fusion li-
brary. 50 mM 3-amino-1,2,4-triazole (3-AT) was used to control
for promiscuous HIS3 expression. Transformants were grown on
defined medium lacking histidine at 308C for 6–10 d. Gal4-
cDNA fusions with activity were isolated from the yeast and their
DNA sequences were determined.
Results
First we isolated and sequenced several overlapping ge-
nomic clones from a human bone marrow genomic library
using a HOXB4 cDNA. The human HOXB4 gene con-
tains two exons separated by a single intron. Comparison
of the human and mouse sequences indicates that the hu-
man HOXB4 gene encodes a protein nearly identical to its
murine homologue. The human and mouse homeobox
genes also contain regions of significant homology in non-
coding sequences. Most notably, the 240 bp immediately
59 to the ATG initiation codon in the human HOXB4
gene are 97% identical to the corresponding mouse se-
quences (Fig. 1) (19).
Northern analysis and reverse transcriptase PCR were
used to survey several human leukemic cell lines to identify
suitable candidates for the study of HOXB4 regulation.
HOXB4 RNA was expressed at moderate levels in K5621482 USF-1 and USF-2 Activate the HOXB4 Gene in Stem Cells
cells, and at lower levels in U937 and KG1a cells. Nuclear
run-on experiments in K562 cells demonstrated that
HOXB4 transcription was induced during incubation of
the cells in PMA (Fig. 2).
59 RACE analysis in K562 cell extracts identified two
transcriptional start sites between 65 and 90 bp 59 to an
ATG, initiating a long open reading frame similar to results
found for the murine Hox-b4 gene (not shown) (19).
These results suggested that transcription is initiated within
a short distance of this candidate translation initiating ATG,
and further suggested that these highly conserved proximal
59 sequences might be sites that govern transcriptional reg-
ulation.
Using transient transfection of luciferase reporter con-
structs into K562 cells, we found transcriptional stimulatory
activity in the 688-bp 59 noncoding sequence, but not in
the 39 sequence or in the intronic sequences. This tran-
scriptional activity was localized by deletion analysis to a
99-bp fragment (Fig. 3 A, fragment 11) located 2153 to
255 bp 59 to the ATG. Subdividing this fragment elimi-
nated transcriptional activity from either fragment (Fig. 3
A, fragments 9 and 10). Thus, a region located between
nucleotides 2153 and 255 upstream of the translational
initiation ATG appears to contain the core noncoding
DNA sequences required for HOXB4 transcription in
K562 cells. Similar results with this 99-bp sequence were
also obtained in KG1a and U937 cells (data not shown).
To determine the relationship of these findings in leuke-
mic cell lines to normal stem cell physiology, the transcrip-
tional activity of the 99-bp core promoter sequence
(99bp59HOXB4) was then tested in highly purified imma-
ture CD341 bone marrow cells. TPO, SCF, and Flt-3l,
alone and in combination, have been previously shown to
stimulate human stem cell division while maintaining ele-
ments of stem cell self-renewal (20, 21). To test the re-
sponse of the putative 99-bp HOXB4 promoter to growth
factor stimulation supporting stem cell self-renewal, we
cloned the 99-bp promoter 59 to enhanced green fluores-
cent protein (EGFP), or to luciferase, and transfected these
constructs into CD341 cells that were cultured in the pres-
ence of TPO, SCF, and Flt-3l, for 24–72 h. Under these
culture conditions, expression of a 99bp59/EGFP reporter
was detectable by immunofluorescence in 2–5% of the
electroporated CD341 cells (Fig. 4 A). When the 99bp59/
luciferase construct was electroporated and the CD341 cells
were cultured for 24–72 h in TPO/SCF/Flt-3l, luciferase
activity was stimulated 5–10-fold (Fig. 4 B). In contrast,
culture of CD341 cells in the presence of GM-CSF sup-
ported only minimal HOXB4 promoter–activated tran-
scription and expression of reporter constructs (Fig. 4 C).
Inspecting the DNA sequence within the 99bp59HOXB4
region, we found several consensus protein-binding sites,
including an SP1 site, an NF1 site, a c-myc–like E box, and
a c-myb–binding site (Fig. 5 A). We then determined the
effects of mutations in these consensus sites and other sites
not known to specify binding. Mutation of the NF1 site
Figure 1. DNA sequence of the human HOXB4 and mouse Hox-b4
59 regions. Identical bases are shown in gray, disparate bases in black, and
missing bases as black X’s. The coding sequence beginning with the ATG
is set at 11. Transcription start sites identified by 59 RACE are shown
with arrows. These sequence data, as well as the remainder of the com-
plete HOXB4 genomic clone, are available from EMBL/GenBank/
DDBJ under accession no. AF307160.
Figure 2. HOXB4 expression and transcription in human K526 cells.
(A) Northern analysis. mRNA isolated from K562 cells analyzed with a
HOXB4 39 untranslated region probe. Quantitation was performed by
PhosphorImager, with glyceraldehyde 3-phosphate dehydrogenase (G3PDH)
used as an internal control. (B) Nuclear run-on. Newly translated RNAs
from nuclei isolated from K562 cells either before or after PMA induction
were radiolabeled, extracted, and hybridized to HOXB4 or nonspecific
probes.1483 Giannola et al.
(ATTGGCT to AACGGCT) inhibited transcriptional ac-
tivity in transient transfection assays 60–80%, mutation of
the E box (CACGTG to CATATG) inhibited promoter
activity 90–95%, while mutations of several other sites, in-
cluding candidate SP1 and c-myb–binding sites, had no ef-
fect (Fig. 5 B).
To confirm these sites identified in transient transfection
assays, stable cell pools of K562 cells transfected with the
native or mutated 99-bp promoter were created. K562 cells
were cotransfected with plasmids with resistance to G418
along with plasmids encoding either the native or mutated
promoter linked to luciferase. Stable transformant pools
were selected in G418, and each pool was analyzed for lu-
ciferase production after 3 wk. As with the transient assays,
luciferase activation via the HOXB4 promoter was inhib-
ited by mutations at either site, and was essentially abol-
ished by mutation of the E box site (Fig. 5 C). Based on
these results, we have termed these two sites within the
HOXB4 promoter HXRE-1 and HXRE-2.
These results, and in particular the strong effect of
HXRE-2 mutation on transcriptional activation, suggested
that transcription factors required for HOXB4 expression
Figure 3. Transient transfection of K562
cells with 59 HOXB4/luc constructs. Frag-
ments encompassing bases (2584 to 104)
were tested for their ability to support lu-
ciferase transcription. Data shown are pre-
sented in relative luminescence units (RLU)
normalized to bgal, and come from one of
four similar experiments. The strongest pro-
moter activity was detected in fragment 11
(2153 to 255); subfragments of 11 (frag-
ments 9 and 10) had only baseline activity.
Figure 4. Activation of the
HOXB4 promoter construct in
normal CD341 bone marrow
cells. Immunopurified CD341
bone marrow mononuclear cells
were electroporated with
HOXB4 promoter constructs
linked either to GFP, for direct
visualization, or to luciferase for
relative quantitation of pro-
moter activation. (A) Immu-
nopurified (.97%) CD341 bone
marrow  cells were electropo-
rated with the 99bp59HOXB4/
EGFP after culture in SCF (100
ng/ml), TPO (100 ng/ml), and
Flt-3l (100 ng/ml) for 48 h, and
cells expressing EGFP were visu-
alized by fluorescence micros-
copy (original magnification:
320). (B) CD341 cells were cul-
tured in SCF/TPO/Flt-3l for
24–72 h, and then electroporated
with 99bp59HOXB4/luc (gray
bars) or with control PCI-luc
(black bars). (C) 99bp59HOXB4/
luc transfected CD341 cells cul-
tured for 72 h in SCF/TPO/Flt-
3l or in GM-CSF (20 ng/ml) be-
fore electroporation. The CD341
cells cultured in SCF/TPO/Flt-
3l for 72 h generated cultures in
which 12.2% of the cells remained CD341 whereas 9.75% acquired CD11b. CD341 expression on cells cultured in GM-CSF declined to 2.2%, and
32.3% acquired CD11b. Lysates were assayed in triplicate for luciferase activity, and results were normalized with renilla luciferase in each sample. Inter-
sample variability was ,15%.1484 USF-1 and USF-2 Activate the HOXB4 Gene in Stem Cells
bound to these sites. We next performed EMSAs using ra-
diolabeled 20-bp probes containing the HXRE-2 site. In-
cubation of K562 nuclear extracts with this resulted in a
clear and reproducible pattern of protein–DNA complexes.
Several of these were significantly diminished by 50-fold
molar excess of unlabeled nonspecific oligonucleotide (Fig.
6 A, lane 4). Others were not, but were specifically dimin-
ished or eliminated by coincubation with competitor DNA
corresponding to the 20-bp probe (Fig. 6 A, lane 3). These
data suggested that the retarded bands were caused by spe-
cific interactions between K562 nuclear proteins and the
promoter oligonucleotide.
To identify HXRE-2–binding transcription factors, we
next performed a series of yeast one hybrid selection exper-
iments (22). We used the core HXRE-2 sequences as the
binding target and the K562 and bone marrow cDNA li-
braries as the sources of potential transcription factors. Us-
ing this technique we isolated several clones for each of the
two transcription factors, USF-2 and MITF. USF-2, a
member of the helix-loop-helix (HLH) family of DNA
binding is widely expressed (23–25) and often binds as a
homodimer or as a heterodimer with USF-1 (26, 27).
USF-1 and/or USF-2 control the transcription of many
genes critical to basic cell metabolism, including pyruvate
kinase (28), fatty acid synthase (29), and the mitochondrial
ATP synthase complex a subunit (30). Surprisingly, the
yeast one hybrid screens did not identify any cDNAs en-
coding human USF-1. On the other hand, the screen did
identify MITF, another HLH transcription factor whose
mutation causes micropthalmia, mast cell and skin pigmen-
tation defects in mice (31, 32), and Waardenburg syndrome
type 2 (autosomal dominant hearing loss and depigmenta-
tion) in humans (33). MITF appears to be a dominant tran-
scription factor for melanocyte-specific genes, including ty-
rosinase (34), tyrosinase-related protein 1 (35), and mast
cell proteases 5 and 6 (36–38). Of particular interest, MITF
activates mast cell–specific genes in response to c-kit activa-
tion by SCF (39, 40).
To determine whether USF-2, MITF, and their respec-
tive heterodimeric binding partners USF-1 and TFE3 are,
in fact, present in K562 nuclear extracts and capable of
binding to HOXB4 HXRE-2 sites, we performed EMSAs
in the presence of transcription factor–specific antibodies.
Specific antibodies to TFE3, c-myc, and E47 neither elim-
inated EMSA bands nor generated higher mobility super-
shifted bands when preincubated with labeled HXRE-2
probe. In contrast, altered mobility shift patterns were cre-
ated by coincubation of either anti–USF-1, anti–USF-2, or
anti-MITF. Anti–USF-1 shifted the dominant band in the
middle of the electrophoresis pattern, creating complexes
of lower mobility. Anti–USF-2 decreased but did not elim-
inate the intensity of the major band, and created a new
band of the same mobility as one of the anti–USF-1 shifted
bands. Anti-MITF blocked the appearance of the fastest
mobility band, creating a new band of slightly larger size
(migrating slightly faster than the dominant band in the
control incubation). When anti–USF-1 and anti–USF-2
were added together with nuclear extracts and labeled
probes, additional shifts to larger complexes were found.
When anti-MITF was added along with anti–USF-1, the
effects were additive and no new bands were seen (Fig. 6
B). These supershift patterns show that USF-1, USF-2, and
MITF are present in K562 nuclear extracts and bind to the
HXRE-2 site.
To assess the functional consequences of these transcrip-
tion factors binding to HXRE-2 in hematopoietic cells,
cotransfection experiments were performed measuring the
effect of enforced expression of each of these proteins, or of
their dominant negative mutants, on transcriptional activa-
tion of luciferase reporter constructs via the core HOXB4
promoter. Overexpression of either USF-1, USF-2, or
both USF-1 and USF-2 in K562 cells activated HOXB4
promoter transcription two- to fourfold. In contrast, MITF
Figure 5. Identification of critical sequences within the HOXB4 core
promoter via transient and stable transfection in K562 cells. (A) DNA se-
quence of the 99bp59HOXB4 promoter, with candidate protein-binding
sites shown in red and the mutated sequences shown in green. (B) Tran-
sient transfection of luciferase reporter constructs including the native
HOXB4 promoter, HOXB4 promoter mutated (mut) at the NF1
(HXRE-1) site (TT to AC), or mutated at the E box (HXRE-2)(CG to
TA). (C) Luciferase production over 24 h in stable K562 cell pools
cotransfected and selected with the same constructs. In transient transfec-
tion, mutation at HXRE-1 inhibited transcription via the promoter 60–
80%, and mutation at HXRE-2 inhibited 90–95%. In stably transfected
cells, HXRE-1 mutation inhibited transcription 85–90%, and HXRE-2
mutation 95–98%. Results are shown from one of three similar experi-
ments for each set and are presented as means 6 SD of triplicate measure-
ments. RLU, relative luminescence units.1485 Giannola et al.
overexpression did not activate transcription, but in some
experiments actually depressed transcription somewhat
(Fig. 7 A). Expression of the endogenous HOXB4 mRNA
was similarly induced two- to threefold in K562 cells tran-
siently transfected with USF-1 or USF-2 expression plas-
mids (Fig. 7 B). This level of HOXB4 mRNA induction
may underrepresent the stimulatory effects of USF overex-
pression, as the efficiency of K562 cell electroporation is
only 50–60%, whereas the Northern blot analysis measures
the (averaged) HOXB4 expression in transfected and un-
transfected cells. Overexpression of a dominant negative
mutant USF (D/N USF) depressed basal HOXB4 tran-
scription in K562 cells 30–60%, but D/N MITF had no
measurable effect (Fig. 7 C). These data suggest that USF-1
and USF-2 independently can upregulate HOXB4 tran-
scription, that USF-1 and/or USF-2 are responsible for
HOXB4 basal transcription in K562 cells, and that MITF
has neither a basal nor a stimulatory effect.
Figure 6. Detection of nuclear
proteins specifically binding to the
HOXB4 promoter by EMSA. (A)
Radiolabeled 99-bp HOXB4 oligo-
nucleotide probes (fragment 11 from
Fig. 3) were incubated with K562
nuclear extracts, with or without
cold competitor (Comp) oligonucle-
otides as shown, and electrophoresed
through a 4% acrylamide gel. Com-
petition with 50-molar excess probe
(2153 to 255 bp fragment 11, Fig.
3) specifically blocked nuclear pro-
tein binding to this probe, eliminat-
ing bands which were not elimi-
nated by competition with unrelated
probe (NS, nonspecific probe). (B)
Antibodies to USF-1, USF-2, and
MITF were incubated with K562
nuclear extracts and labeled HXRE-2
probe, and electrophoresed through
4% acrylamide. Each antibody alone
retards specific bands in the control
EMSA, and combinations of two or
three antibodies have additive ef-
fects. These supershifts show that
USF-1, USF-2, and MITF are present
in K562 nuclear extracts and bind to
the HXRE-2 site in HOXB4.
Figure 7. Effects of cotransfection of USF
and MITF expression plasmids on transcrip-
tional activation of HOXB4 promoter
(HXRE-2) construct and on endogenous
HOXB4 expression, in K562 cells. (A)
HOXB4/luc transcription after cotransfec-
tion with expression plasmids encoding
MITF, USF-1, or USF-2. Each bar indicates
the mean 6 SD of quadruplicate measure-
ments in a single experiment, from one of
four similar experiments. (B) Northern anal-
ysis of the K562 cell HOXB4 mRNA ex-
pression after transient transfection with
USF-1 and USF-2 expression plasmids. 5
mg polyA1 RNA from 100 3 106 K562
cells was loaded in each lane, and both gly-
ceraldehyde 3-phosphate dehydrogenase
(G3PDH) and b-actin were used as internal
controls. (C) 99bp59HOXB4/luc transcrip-
tion after cotransfection with D/N MITF or
D/N USF. The data shows mean 6 SD of
quadruplicate measurements in a single ex-
periment, from one of three similar experi-
ments. RLU, relative luminescence units.1486 USF-1 and USF-2 Activate the HOXB4 Gene in Stem Cells
Studies by Hemesath et al. have indicated that activation
of melanocytic cell lines to upregulate MITF to induce ty-
rosinase transcription is mediated by the RAS/MAPK
pathway (40). Although MITF does not activate the
HOXB4 promoter, we hypothesized that MITF and USF-
1/2 might play analogous roles in aspects of lineage-specific
transcription and self-renewal favoring transcription, re-
spectively. If this were true, perhaps the RAS pathway
might be involved in activation of the HOXB4 promoter
in cells capable of activating its transcription. To test this, a
plasmid encoding constitutively activated (V12) RAS was
cotransfected into K562 along with the HOXB4/luc con-
struct. V12 RAS cotransfection induced HOXB4/luc ex-
pression fivefold. RAS activation of HOXB4/luc was
blocked by cotransfection with plasmids encoding  D/N
MEK, or by incubation with the soluble pharmacologic
MEK inhibitor PD98059, but not by cotransfection with a
plasmid encoding D/N (Dp85) PI3K (Fig. 8 A). D/N
MEK and PD98059, but not D/N PI3K, also inhibited
basal HOXB4/luc expression, suggesting that the MAPK
pathway was also involved in basal HOXB4 transcription
(Fig. 8 B). This interpretation was supported by the find-
ings that D/N USF blocked RAS activation of HOXB4/
luc, and that cotransfection of V12 RAS and USF-1 led to
synergistic activation of HOXB4/luc (Fig. 8 C). Finally,
cotransfection of V12 RAS along with an HXRE-2 (E
Box) mutated HOXB4/luc failed to activate the promoter,
whereas V12 RAS transfection along with HXRE-1 mu-
tant HOXB4/luc caused partial activation (Fig. 8 D). This
suggests that the HXRE-2 (E box) site is required for RAS
activation of the HOXB4 promoter.
To further test the role of USF transcription factors in
activation of the HOXB4 promoter in stem cells, cotrans-
fection experiments were then performed with HOXB4/
Figure 8. Interaction of the RAS/MAPK pathway and the HOXB4 promoter. K562 cells were transiently transfected with 3 mg of the 99-bp
HOXB4 promoter construct, along with the indicated expression plasmid constructs. (A) RAS activates the HOXB4 promoter. 5 mg plasmids encoding
constitutively activated RAS, along with 10 mg PCI vector (control), D/N MEK, D/N PI3K, the soluble MEK inhibitor 100 mM PD98059 (in
DMSO), or DMSO alone were cotransfected along with the HOXB4 promoter, and luciferase activity was measured at 48 h. (B) Basal activity of the
HOXB4 promoter is transmitted via the RAS/MAPK pathway. Plasmids encoding D/N MEK, D/N PI3K, PCI, or 100 mM PD98059 were cotrans-
fected along with the HOXB4 promoter. (C) RAS activation of the HOXB4 promoter is transmitted via USF. HOXB4 promoter activation induced by
cotransfection of plasmid encoding activated RAS is blocked by D/N USF, but not D/N MITF, and HOXB4 activation by cotransfected RAS plus
USF-1 is higher than either alone. (D) RAS activation of the HOXB4 promoter requires an intact HXRE-2 (E box) site. Intact HOXB4 promoter/luc
reporter construct, and HXRE-1–mutated HOXB4 promoter are activated by V12 RAS, but HXRE-2 (E box)–mutated HOXB4 promoter/luc re-
porter is not activated by RAS. Each bar indicates the mean 6 SD of quadruplicate measurements in a single experiment, from one of three to four sim-
ilar experiments.1487 Giannola et al.
luc and USF-1, USF-2, or D/N USF in normal primary
CD341 bone marrow cells. In these assays, overexpression
of either the USF-1 or USF-2 protein activated the
HOXB4 promoter 5–20-fold, indicating that USF-1 and
USF-2 are able to activate the promoter in normal cells.
Consistent with this, expression of the D/N USF protein
blocked HOXB4 promoter activity 40–80%, indicating
that USF-1 and/or USF-2 bind to and activate the
HOXB4 promoter in CD341 cells stimulated to divide and
self-renew in the presence of TPO, SCF, and Flt-3l (Fig.
9). Taken together, these data suggest that USF-1 and
USF-2 mediate the activation of the HOXB4 gene in hu-
man stem cells undergoing proliferation accompanied by
self-renewal.
Discussion
These studies identify and characterize the human
HOXB4 promoter in an attempt to identify the regulatory
proteins that help maintain normal hematopoietic stem cell
self-renewal and homeostasis. The results of these studies
include: (a) identification of the genomic regulatory se-
quences responsible for regulating human hematopoietic
stem cell HOXB4 expression, both in normal bone mar-
row cells and in leukemic cell lines; (b) demonstration that
these sequences mediate HOXB4 transcription differen-
tially in response to hematopoietic growth factors that
stimulate stem cell self-renewal; and (c) identification of
USF-1 and USF-2 as transcription factors that bind to and
can activate the HOXB4 promoter in stem cells.
Comparison of the murine Hox-b4 and human HOXB4
genes showed areas of high homology, particularly within
the proximal 59 sequences (19). The most proximal of these
regions, located within 200 bp of the translation initiation
ATG, was .97% homologous between species, and con-
tained strong HOXB4 regulatory activity. Transient trans-
fection assays in K562 cell lines first identified a 99-bp 59
regulatory region that was necessary and sufficient for
HOXB4 expression. Expression driven by this construct
declined with PMA-induced differentiation, suggesting
that this construct might be sufficient to transmit downreg-
ulated expression with differentiation as well, a feature es-
sential to HOXB4 function in vivo (41). This same con-
struct was active in normal CD341 bone marrow cells,
comprising the most primitive 1% of hematopoietic cells.
These findings are notable in light of the elegant studies
in mice and chickens by Krumlauf, Whiting, Gould, and
colleagues (41–43). These investigators found that neural
specific expression of HOXB4 is dictated, both in space
and time, by enhancer elements located within the
HOXB4 intron and 39 to the HOXB4 exons. These 39
regulatory elements include potential PBX-binding sites
between the HOXB4 and HOXB3 genes which appear to
be candidates for cross-regulation by HOX proteins (43).
In addition, a more distal retinoic acid response element lo-
cated within the HOXB3 gene itself (44) might regulate
the induction of both these genes by retinoic acid (45, 46).
These authors also found that sequences localized to the
immediate 39 noncoding region were responsible for ex-
pression of HOXB4 within the developing mouse lung
(42). In the present study, we found that proximal 59 se-
quences are sufficient to drive HOXB4 transcription in
primitive normal and malignant hematopoietic stem cells,
and to downregulate HOXB4 transcription in response to
growth factors and biochemical inducers that stimulate loss
of stem cell self-renewal and differentiation. However, it is
possible that the 39 neural enhancers might have modula-
tory roles, interacting with core 59 promoter–driven tran-
scription, in normal or malignant human hematopoiesis.
Transcriptional activation via the 59 HOXB4 promoter
was induced in CD341 hematopoietic cells by culture in
the hematopoietic growth factors TPO, SCF, and Flt-3l.
The CD341 hematopoietic cell pool includes extremely
primitive pluripotent stem cells capable of self-renewal, as
well as lineage-restricted but phenotypically immature pro-
genitor cells. HOXB4 transcription is found to be highest
in the most primitive CD341 stem cells, but is distinctly
lower in more differentiated cell compartments (6). More-
over, overexpression of HOXB4 has been found to confer
increased stem cell self-renewal, as measured in competitive
repopulation assays (13). Using a variety of approaches, in-
Figure 9. USF-1 and USF-2 activate the 99bp59HOXB4 regulatory
element in normal CD341 bone marrow cells. Immunoselected CD341
cells were electroporated with 99bp59HOXB4/luc, with or without ex-
pression plasmids encoding USF-1 (A and B) USF-2 (A), or D/N USF
(B). The data are expressed as mean 6 SD of triplicate samples and are
taken from one of three similar experiments.1488 USF-1 and USF-2 Activate the HOXB4 Gene in Stem Cells
cluding studies of mutant mouse strains, long-term bone
marrow cultures, and competitive repopulation transplanta-
tion, investigators have implicated TPO, SCF, and Flt-3l as
each supporting stem cell self-renewal, and the combina-
tion of the three hormones appears to be notably effective
(20). The observation that HOXB4 transcription via the
99-bp 59 promoter was highly induced by the CD341 cul-
ture in TPO/SCF/Flt-3l and far less so during culture in
GM-CSF strongly suggests that these hormones, at least in
part, trigger their maintenance of stem cell maintenance
and self-renewal via these sequences. Of particular note,
CD341 cells proliferated to a comparable extent over 72 h
in either TPO/SCF/Flt-3l or GM-CSF, indicating that the
HOXB4 promoter induction was not simply indicative of
cell cycling. However, CD341 cells cultured in SCF/
TPO/Flt-3l for 72 h generated cultures in which 12.2% of
the cells remained CD341 whereas 9.75% acquired CD11b,
only 2.2% of CD341 cells cultured in GM-CSF remained
CD341, and 32.3% acquired CD11b.
Yeast one hybrid screens identified USF-1, USF-2, and
MITF as candidates for transcription factors mediating
HOXB4 activation through HXRE-2. Supershift EMSAs
showed that each of these proteins was present in K562 ex-
tracts and capable of specific binding to the HXRE-2 site.
Cotransfection assays based on these results demonstrated
that of these three transcription factors, USF-1 and USF-2
can activate HOXB4 promoter constructs. Overexpression
of USF-1 and USF-2 can also upregulate endogenous
HOXB4 expression, to an extent similar to that seen with
the HOXB4 promoter constructs. These findings support
the recent findings that USF-2 is upregulated in response to
IL-3 in the IL-3–responsive leukemic cell line (38), and
provide a molecular explanation for how this induction
might promote leukemic cell proliferation. In addition, the
findings that either USF-1 or USF-2 can independently ac-
tivate the HOXB4 promoter, but MITF does not, may ex-
plain why the USF-1/USF-2 double knockout mice die
early in embryogenesis (47).
MITF contrasts with USF-1 and USF-2 in its interaction
with the HOXB4 promoter. On the one hand, anti-MITF
antibodies clearly detect extractable nuclear MITF protein
capable of binding to the HXRE-2 E box site within the
HOXB4 promoter. However, cotransfection of K562 cells
(or CD341 cells) with plasmids encoding MITF (and capa-
ble of activating the tyrosinase promoter in melanocyte cell
lines) does not transcriptionally activate HOXB4. Rather,
overexpression of MITF results in no change, or in some
experiments, slight diminution of HOXB4 activation.
Thus, MITF appears to be a neutral potential occupant of
the HOXB4 promoter. These findings are of note in light
of the recent studies of Hemesath et al. (40), who demon-
strated that MITF plays a central role in melanocyte differ-
entiation. In these studies, stimulation of melanocytic cell
lines by SCF causes activation of the RAS pathway, leading
to the transcriptional activation of the tyrosinase gene via
the phosphorylation of MITF. This is particularly interest-
ing, inasmuch as SCF plays a role in both stem cell prolifer-
ation and melanocyte differentiation. In these studies, RAS
activation likewise resulted in the activation of the
HOXB4 promoter; however, MITF expression does not
induce this effect. These results suggest that the complex
patterns of self-renewal and differentiation displayed by
stem cells in response to individual and multiple growth
factors might be explained by their activation of specific
patterns of transcription factors, and that the basic HLH
zipper proteins are likely included among such proteins.
In summary, the human homeobox gene HOXB4,
which plays a pivotal role in stem cell self-renewal and ho-
meostasis, is transcriptionally regulated in hematopoietic
stem cells via a 99-bp core promoter sequence. This se-
quence contains a consensus E box site to which USF-1,
USF-2, and MITF bind, and their the balanced activities
can regulate the transcription of the HOXB4 gene. Further
studies of human stem cell HOX gene regulation can now
explore distinct models of transcriptionally regulated self-
renewal versus differentiation-specific pathways. These
studies should contribute directly to our understanding of
the molecular mechanisms of normal cell and tissue ho-
meostasis as well as dysplasia and transformation.
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